DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Tioclomarol

Tioclomarol

  • (12) United States Patent (10) Patent No.: US 9,498,481 B2 Rao Et Al

    (12) United States Patent (10) Patent No.: US 9,498,481 B2 Rao Et Al

  • Asymmetric Organocatalyzed Synthesis of Coumarin Derivatives

    Asymmetric Organocatalyzed Synthesis of Coumarin Derivatives

  • Characterising the Risk of Major Bleeding in Patients With

    Characterising the Risk of Major Bleeding in Patients With

  • Reactivity and Alkylating Potential of Some O-Heterocycles

    Reactivity and Alkylating Potential of Some O-Heterocycles

  • Subarachnoid Haemorrhage

    Subarachnoid Haemorrhage

  • A2) United States Patent (0) Patent No.: US 9,078,919 B2 Olsonet Al

    A2) United States Patent (0) Patent No.: US 9,078,919 B2 Olsonet Al

  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

    Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

  • Heparin EDTA Patent Application Publication Feb

    Heparin EDTA Patent Application Publication Feb

  • Study Protocol

    Study Protocol

  • 9719087.Pdf (3.190Mb)

    9719087.Pdf (3.190Mb)

  • Proposed Classification of Resistances to Oral Anticoagulant Therapy

    Proposed Classification of Resistances to Oral Anticoagulant Therapy

  • BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available

    BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available

  • CHAPTER 1 General Introduction

    CHAPTER 1 General Introduction

  • Wo 2011/060944 A2

    Wo 2011/060944 A2

  • (12) United States Patent (10) Patent No.: US 8,835,407 B2 Mosher Et Al

    (12) United States Patent (10) Patent No.: US 8,835,407 B2 Mosher Et Al

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Public Assessment Report Scientific Discussion Orivast 10 Mg, 20 Mg, 40 Mg, 80 Mg Film-Coated Tablets

    Public Assessment Report Scientific Discussion Orivast 10 Mg, 20 Mg, 40 Mg, 80 Mg Film-Coated Tablets

  • Exploring Adverse Drug Events at the Class Level Rainer Winnenburg1, Alfred Sorbello2 and Olivier Bodenreider3*

    Exploring Adverse Drug Events at the Class Level Rainer Winnenburg1, Alfred Sorbello2 and Olivier Bodenreider3*

Top View
  • Stembook 2018.Pdf
  • Tinzaparin Sodium(BAN, USAN, Rinn)
  • Head Injury Partial Update
  • Subarachnoid Haemorrhage
  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
  • Marrakesh Agreement Establishing the World Trade Organization
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Electronic Counselling for Oral Anticoagulant Patients Khulud Tariq
  • Port EU Post
  • Review of the Square Box Symbol Uses
  • ( 12 ) United States Patent
  • Pharmaceutical Compositions Comprising Prasugrel And
  • ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
  • NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
  • Direct Oral Anticoagulants Versus Vitamin K Antagonists for Patients with Left Ventricular Thrombus: a Systematic Review and Meta­‑Analysis
  • ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
  • Customs Tariff - Schedule Xxi - 1
  • Australian Statistics on Medicines 2009


© 2024 Docslib.org    Feedback